• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer.

作者信息

Kwong Ava, Wong L P, Wong H N, Law F B F, Ng E K O, Tang Y H, Chan W K, Ho L S, Kwan K H, Poon M, Wong T T, Leung F C S, Chan S W W, Ying M W L, Ma E S K, Ford J M

出版信息

Breast Cancer Res Treat. 2009 Oct;117(3):683-6. doi: 10.1007/s10549-009-0385-2. Epub 2009 Apr 8.

DOI:10.1007/s10549-009-0385-2
PMID:19353265
Abstract
摘要

相似文献

1
A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer.中国南方乳腺癌和卵巢癌女性中的一种BRCA2始祖突变及七种新的有害BRCA突变。
Breast Cancer Res Treat. 2009 Oct;117(3):683-6. doi: 10.1007/s10549-009-0385-2. Epub 2009 Apr 8.
2
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population.卵巢癌中BRCA1和BRCA2种系突变的复发：在中国人群中鉴定出的一种BRCA1的始祖突变。
Hum Mutat. 2002 Mar;19(3):307-8. doi: 10.1002/humu.9015.
3
Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.采用基因测序和高分辨率 DNA 熔解分析鉴定中国南方乳腺癌患者中的 BRCA1/2 种系突变。
PLoS One. 2012;7(9):e43994. doi: 10.1371/journal.pone.0043994. Epub 2012 Sep 7.
4
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.西班牙乳腺癌/卵巢癌患者中BRCA1和BRCA2基因分析：西班牙特有的高比例突变及奠基者效应证据
Hum Mutat. 2003 Oct;22(4):301-12. doi: 10.1002/humu.10260.
5
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.韩国高风险非家族性乳腺癌患者中 BRCA1 和 BRCA2 突变的流行率：韩国遗传性乳腺癌（KOHBRA）研究。
Breast Cancer Res Treat. 2012 Jun;133(3):1143-52. doi: 10.1007/s10549-012-2001-0. Epub 2012 Mar 2.
6
[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].[加拿大魁北克奠基人群体法裔加拿大乳腺癌和乳腺-卵巢癌家族中致病性BRCA1和BRCA2突变的有限谱]
Bull Cancer. 2006 Sep;93(9):841-6.
7
BRCA1 and BRCA2 mutations in Russian familial breast cancer.俄罗斯家族性乳腺癌中的BRCA1和BRCA2基因突变
Hum Mutat. 2002 Feb;19(2):184. doi: 10.1002/humu.9008.
8
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.517个荷兰乳腺癌和/或卵巢癌家族中不同BRCA1/BRCA2突变频率存在较大的地区差异。
Eur J Cancer. 2001 Nov;37(16):2082-90. doi: 10.1016/s0959-8049(01)00244-1.
9
Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer.在新加坡亚洲乳腺癌和卵巢癌患者中鉴定新型BRCA大基因组重排
Clin Genet. 2007 Apr;71(4):331-42. doi: 10.1111/j.1399-0004.2007.00773.x.
10
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.对989例乳腺癌或卵巢癌患者的综合分析提供了德国人群中BRCA1和BRCA2的突变谱及频率。
Int J Cancer. 2002 Feb 1;97(4):472-80. doi: 10.1002/ijc.1626.

引用本文的文献

1
BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients.中国客家乳腺癌患者的 BRCA1 和 BRCA2 种系突变。
BMC Med Genomics. 2024 Jan 2;17(1):3. doi: 10.1186/s12920-023-01772-9.
2
Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.BRCA1 和 BRCA2 种系变异在中国客家乳腺癌和卵巢癌患者中的分析。
BMC Cancer. 2022 Aug 2;22(1):842. doi: 10.1186/s12885-022-09943-0.
3
Assessing the Variations in Breast/Ovarian Cancer Risk for Chinese Carriers.评估中国携带者患乳腺癌/卵巢癌风险的差异。
J Oncol. 2022 Mar 26;2022:9390539. doi: 10.1155/2022/9390539. eCollection 2022.
4
The Features of and Germline Mutations in Hakka Ovarian Cancer Patients: C.536 A>T Maybe a Founder Mutation in This Population.客家卵巢癌患者中 和 种系突变的特征：C.536 A>T可能是该人群中的一个始祖突变。
Int J Gen Med. 2022 Mar 10;15:2773-2786. doi: 10.2147/IJGM.S355755. eCollection 2022.
5
Mutational analysis of BRCA1 and BRCA2 in northwest Chinese breast cancer patients.中国西北乳腺癌患者中BRCA1和BRCA2的突变分析。
Transl Cancer Res. 2019 Sep;8(5):1845-1852. doi: 10.21037/tcr.2019.08.32.
6
Prognostic Impact of and Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients.埃及女性乳腺癌患者中[具体基因]突变对长期生存结果的预后影响
Biology (Basel). 2021 Jun 22;10(7):566. doi: 10.3390/biology10070566.
7
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in Genes.意大利南部（西西里岛）家族性遗传性乳腺癌和卵巢癌——基因中致病变异的患病率及地理分布
Cancers (Basel). 2020 May 5;12(5):1158. doi: 10.3390/cancers12051158.
8
Fertility preservation in BRCA mutation carriers-efficacy and safety issues: a review.BRCA 基因突变携带者的生育力保存：疗效和安全性问题的综述。
Reprod Biol Endocrinol. 2020 Feb 18;18(1):11. doi: 10.1186/s12958-019-0561-0.
9
DNA Methylation Profiles and Their Diagnostic Utility in BC.BC 中的 DNA 甲基化图谱及其诊断效用。
Dis Markers. 2019 May 6;2019:6328503. doi: 10.1155/2019/6328503. eCollection 2019.
10
Identifying a c.5722_5723del mutation in a Han-Chinese family with breast cancer.鉴定一个汉族乳腺癌家系中的 c.5722_5723del 突变。
Biosci Rep. 2019 Apr 30;39(4). doi: 10.1042/BSR20182471.